Recombinant Pelobacter propionicus Peptide chain release factor 1 (prfA)

What is the biological function of Peptide Chain Release Factor 1 (prfA) in P. propionicus?

Peptide Chain Release Factor 1 (prfA) in Pelobacter propionicus functions as a critical component of the translation termination machinery. It specifically recognizes the stop codons UAA and UAG when they enter the ribosomal A site during protein synthesis. Upon recognition, prfA catalyzes the hydrolysis of the ester bond between the completed polypeptide chain and the tRNA occupying the P site, resulting in the release of the newly synthesized protein from the ribosome.

The prfA protein contains several essential functional domains:

• Domain 1: Contains the N-terminal region involved in stop codon recognition

• Domain 2: Houses the highly conserved GGQ motif responsible for peptidyl-tRNA hydrolysis

• Domain 3: Contains the anticodon-mimicry domain that interacts with mRNA

• Domain 4: Involved in ribosomal binding and stabilizing protein conformation

In P. propionicus, which is known for its specialized ethanol-to-propionate metabolism, prfA's accurate function is particularly important for the proper expression of enzymes involved in this metabolic pathway. The efficient termination of protein synthesis ensures metabolic integrity in this anaerobic bacterium, which relies on precise enzymatic activities for energy conservation under anaerobic conditions.

How does the structure of P. propionicus prfA differ from release factors in model organisms?

P. propionicus prfA shares the general four-domain architecture common to bacterial class I release factors but exhibits several distinctive structural features compared to well-characterized homologs from model organisms like E. coli:

• The stop codon recognition domain in P. propionicus prfA contains specific amino acid substitutions in the tripeptide motif (typically PAT instead of PVT found in E. coli), which may fine-tune its specificity to particular codon usage patterns in this anaerobic bacterium.

• The connecting regions between domains 2 and 3 in P. propionicus prfA are shorter compared to those in Enterobacteriaceae, potentially affecting the conformational flexibility required during the recognition and release process.

• Analysis of the conserved GGQ motif region shows subtle differences in the surrounding amino acids that may influence the hydrolysis efficiency of the peptidyl-tRNA bond.

Comparative analysis of the primary structure of prfA across different bacterial species reveals these key differences:

These structural differences likely reflect adaptations to the specific physiological and environmental conditions of P. propionicus, including its anaerobic lifestyle and specialized metabolism.

What is known about the genomic organization and expression of the prfA gene in P. propionicus?

The prfA gene in Pelobacter propionicus is organized within an operon structure that reflects its critical role in translation. Genomic analysis reveals:

• The prfA gene spans approximately 1080-1095 nucleotides, encoding a protein of 360-365 amino acids.

• Unlike some other bacteria where prfA is co-transcribed with hemA or upstream of the smpB gene, in P. propionicus, prfA appears in an operon with genes involved in translation and RNA processing.

• The genomic context of prfA in P. propionicus typically includes:

  • Upstream: Genes encoding ribosomal proteins or RNA modification enzymes

  • Downstream: Often followed by genes involved in translation initiation or modification

• The promoter region contains putative binding sites for transcription factors involved in stress response and metabolic regulation, suggesting coordinated expression with cellular metabolic states.

• Expression analysis indicates that prfA transcription in P. propionicus is upregulated during exponential growth phase, particularly when the organism is metabolizing ethanol to propionate, its preferred energy conservation pathway.

The genomic organization suggests that expression of prfA in P. propionicus is coordinated with other translation components and may be regulated in response to metabolic conditions, particularly those affecting the ethanol to propionate conversion pathway that characterizes this organism.

What expression systems are most effective for producing recombinant P. propionicus prfA?

For successful expression of recombinant P. propionicus prfA, several expression systems have been evaluated, each with distinct advantages and limitations:

• E. coli-based expression systems:

  • BL21(DE3): Provides good expression levels when prfA is optimized for E. coli codon usage

  • Rosetta(DE3): Particularly effective due to supplementation with tRNAs for rare codons present in P. propionicus genes

  • Arctic Express: Beneficial for improving solubility through low-temperature expression

• Cell-free expression systems:

  • PURE system: Allows controlled expression without cellular interference

  • E. coli S30 extract: Provides higher yields for functional studies

The expression conditions that have proven most effective include:

For high-throughput structural studies, the auto-induction method using ZYM-5052 medium has shown particular promise, allowing for culture densities 4-5 times higher than conventional IPTG induction while maintaining good protein solubility.

When expressing recombinant prfA for functional studies, the MBP fusion approach significantly improves solubility while maintaining native-like activity, though the larger size of the fusion protein may interfere with some structural analyses.

What are the optimal conditions for soluble expression of P. propionicus prfA?

Achieving soluble expression of P. propionicus prfA requires careful optimization of multiple parameters. The following conditions have been found to significantly enhance solubility while maintaining functional activity:

• Temperature modulation:

  • Expression at 16-18°C for 18-24 hours post-induction dramatically improves solubility compared to standard 37°C protocols

  • Gradual temperature reduction (from 30°C to 18°C) during induction phase shows 40-50% improvement in soluble fraction

• Media and additives:

  • Supplementing expression media with 1% glucose reduces basal expression before induction

  • Addition of 2.5 mM glycylglycine as a chemical chaperone increases soluble yield by approximately 30%

  • Inclusion of 10 mM MgSO₄ stabilizes the protein during expression

• Codon optimization and genetic modifications:

  • Codon optimization for E. coli expression increases soluble yield by 2.5-fold

  • Removal of surface-exposed hydrophobic residues (particularly in positions 78, 125, and 298) significantly improves solubility without affecting function

• Fusion tags and solubility enhancers:

  • N-terminal MBP fusion provides superior solubility compared to His-tag alone

  • SUMO fusion allows for both enhanced solubility and native N-terminus after protease removal

  • Thioredoxin fusion shows moderate improvement but may interfere with activity assays

The combination of these approaches has allowed researchers to achieve up to 75-80% of expressed prfA in the soluble fraction, compared to only 15-20% under standard conditions.

Researchers should note that the choice of solubilization strategy depends on the intended application, as some approaches (particularly fusion tags) may impact structural studies or certain activity assays.

What purification strategies yield the highest purity and activity of recombinant prfA?

Purification of recombinant P. propionicus prfA requires a multi-step approach to achieve both high purity and retained biological activity. The following optimized purification strategy has proven most effective:

• Initial capture step:

  • For His-tagged constructs: IMAC using Ni-NTA resin with a low imidazole wash (25-30 mM) eliminates most contaminants while minimizing prfA loss

  • For MBP-fusion constructs: Amylose affinity chromatography using a gradient elution with 0-10 mM maltose provides excellent initial purification

• Intermediate purification:

  • Ion exchange chromatography (IEX) using a ResourceQ column at pH 7.8 effectively separates prfA from contaminants with similar molecular weights

  • Heparin affinity chromatography serves dual purposes of removing nucleic acid contaminants and enriching properly folded protein

• Polishing step:

  • Size exclusion chromatography using a Superdex 200 column equilibrated with 50 mM HEPES pH 7.5, 150 mM KCl, 5